https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2020-01-10 15:21:462023-06-14 16:00:01Verona Pharma to Report 4 Week Phase 2b COPD Dose-ranging Study Results with Nebulized Ensifentrine on Top of Tiotropium Therapy
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2020-01-10 15:21:462023-06-14 16:00:01Verona Pharma to Report 4 Week Phase 2b COPD Dose-ranging Study Results with Nebulized Ensifentrine on Top of Tiotropium Therapy
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2020-01-09 15:19:182023-06-14 15:46:27Macrophage Pharma Expands Executive Team with Chief Scientific Officer and Chief Technology Officer
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2020-01-08 15:15:262023-06-14 15:46:36Ori Biotech announces a $9.4M seed round to advance innovation in Cell and Gene Therapy manufacturing
https://www.optimumcomms.com/wp-content/uploads/2023/02/Verona_Logo_300-1.png
180
300
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2020-01-07 15:20:132023-06-14 16:15:22Verona Pharma Appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-12-18 10:06:582023-06-14 16:07:30Edinburgh Molecular Imaging Closes Financing
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-12-11 09:43:262023-06-14 16:07:37Forendo Pharma signs important License and Collaboration Deal with Leading Pharma Company
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-12-09 17:29:392023-06-14 16:07:41STORM Therapeutics’ collaborator awarded ASH–BSH Abstract Achievement Award at the 61st ASH Annual Meeting & Exposition
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-12-09 17:27:552023-06-14 16:13:40ImaginAb Initiates Phase II Clinical Trial at Penn Medicine
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-12-05 09:44:532023-06-14 16:14:04Takeda and Enzyre to Develop Diagnostic Device Allowing Hemophilia Patients to Determine their Coagulation Status at Home
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-12-02 11:46:512023-06-14 16:13:35IXICO to Present Abstracts at Upcoming Clinical Trials on Alzheimer’s Disease Congress
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-12-02 11:31:422023-06-14 16:07:49Owkin Teams up with NVIDIA and King’s College London to Deliver AI to Hospitals While Protecting Patient Data With Federated Learning
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-11-28 09:27:082023-06-14 16:07:55European CNS Specialist Neuraxpharm Expands Southern European Presence with Expansion into Portugal
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-11-26 12:34:392023-06-14 16:08:04Novo Seeds expands company formation activities at BiOrigin with seasoned entrepreneurs
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-11-22 12:28:442023-06-14 16:14:34IXICO Notice of Results
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-11-21 12:20:232023-06-14 16:13:58Azeria Therapeutics announces £32.0 million series B financing
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-11-18 12:18:592023-06-14 16:13:52Castor Establishes Advisory Board of Industry Leaders to Maximize the Impact of its Clinical Data PlatformWe’d love to hear from you
For more information about Optimum Strategic Communications, please get in touch.
